On this page
UPF3B
UPF3B regulator of nonsense mediated mRNA decay
UPF3B is located on the long (q) arm of chromosome X, at band Xq24. Arm ratio per GRCh38 - banding schematic.
Explore chromosome X in the library →Available at Jeen Health
Clinical tests that include this
Overview
UPF3B encodes a core component of the nonsense-mediated mRNA decay pathway, a cellular quality-control system that recognises and destroys faulty messenger RNA transcripts before they can be translated into potentially harmful proteins. This surveillance mechanism is particularly important during brain development, where precise control of gene expression is essential for normal neuronal function. Pathogenic variants in UPF3B have been linked to neurodevelopmental conditions, particularly in males, as the gene is located on the X chromosome. Understanding how UPF3B functions helps explain why disruption of mRNA quality control can affect cognitive development.
What the gene does
The UPF3B protein functions as a regulatory component within the nonsense-mediated decay machinery, working alongside other UPF family proteins to identify messenger RNA transcripts that contain premature termination codons or other features signalling aberrant translation. The protein interacts with UPF2, another essential NMD factor, through a defined binding region spanning its N-terminal portion. UPF3B also associates with the exon junction complex, a group of proteins deposited on mRNA during splicing that serves as a molecular landmark for identifying abnormal transcripts. By bridging these protein complexes, UPF3B helps coordinate the recognition and subsequent degradation of defective mRNA molecules. This quality-control function is thought to be particularly crucial in the developing nervous system, where even modest accumulation of aberrant protein products could disrupt the precise signalling networks required for normal brain function.
Video: Genetics 101
Chromosome location
The UPF3B gene is located on the long arm of the X chromosome at position Xq24. Because the gene resides on the X chromosome, males (who carry only one X chromosome) are typically more severely affected by pathogenic variants than females, who usually have a second, functional copy on their other X chromosome. The X-linked location contributes to the inheritance pattern observed in families carrying UPF3B variants.
Protein structure
The UPF3B protein comprises 483 amino acids and exhibits a modular organisation with distinct functional regions. The N-terminal portion contains a disordered region (amino acids 1-51) followed by a binding site for UPF2 (amino acids 52-57), embedded within a larger region necessary for UPF2 interaction (amino acids 30-255). The central and C-terminal portions of the protein also contain disordered regions (amino acids 206-483), which may provide flexibility for protein-protein interactions. The extreme C-terminus (amino acids 424-483) is sufficient for association with the exon junction complex core, with a narrower segment (amino acids 430-447) being both necessary for binding to RBM8A (a core exon junction complex component) and essential for activating the nonsense-mediated decay pathway.
Key variants
Pathogenic variants in UPF3B have been identified across the gene, including missense changes that alter individual amino acids, nonsense variants that introduce premature stop codons, and deletions that remove portions of the gene. The functional impact of a given variant often depends on whether it disrupts the protein's ability to interact with UPF2 or the exon junction complex, both of which are required for effective mRNA surveillance.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.674_677del | p.Arg225fs | Pathogenic | ★★☆☆ | UPF3B-related disorder |
c.684_685del | p.Glu230fs | Pathogenic | ★★☆☆ | Inborn genetic diseases |
c.697_698del | p.Arg233fs | Pathogenic | ★★☆☆ | Syndromic X-linked intellectual disability 14 |
GRCh37/hg19 Xq24(chrX:118964526-118979535)x0 | - | Pathogenic | ★☆☆☆ | not specified |
c.1081C>T | p.Arg361Ter | Pathogenic | ★☆☆☆ | Syndromic X-linked intellectual disability 14 |
c.16G>T | p.Glu6Ter | Pathogenic | ★☆☆☆ | Inborn genetic diseases |
c.280_283del | p.Tyr94fs | Pathogenic | ★☆☆☆ | Syndromic X-linked intellectual disability 14 |
c.442_443del | p.Asp148fs | Pathogenic | ★☆☆☆ | Syndromic X-linked intellectual disability 14 |
c.617_620del | p.Asn206fs | Pathogenic | ★☆☆☆ | UPF3B-related neurodevelopmental disorder |
c.724C>T | p.Arg242Ter | Pathogenic | ★☆☆☆ | not provided |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Variants in UPF3B are primarily associated with neurodevelopmental conditions affecting cognitive function and intellectual development. Because the gene follows an X-linked inheritance pattern, males carrying a single pathogenic variant typically show more pronounced features than heterozygous females, who may exhibit milder manifestations or remain unaffected due to random X-inactivation patterns. The severity of neurodevelopmental impact can vary among affected individuals, even within the same family.
No condition pages are linked to this gene yet. This does not mean it has no associated conditions.
Inheritance pattern
Conditions caused by pathogenic UPF3B variants typically follow X-linked inheritance.
Carrier frequency by population How common is heterozygous UPF3B carrier status across ancestry groups?UK clinical status
UPF3B is included on the NHS Genomic Medicine Service's Intellectual Disability panel with green (high evidence) classification, reflecting established evidence for its role in neurodevelopmental conditions. The gene also appears on the Developmental Disorders Genotype to Phenotype (DDG2P) database with green status, indicating strong support for its involvement in developmental disorders. These panel memberships mean that UPF3B variants may be reported and interpreted in NHS genomic testing for individuals undergoing evaluation for unexplained intellectual disability or developmental delay.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What does the UPF3B protein do in cells?
The UPF3B protein helps cells identify and destroy faulty messenger RNA molecules through a quality-control process called nonsense-mediated decay. It acts as a bridge between proteins that detect abnormal mRNA features and the machinery that degrades defective transcripts.
Why are males more severely affected by UPF3B variants?
UPF3B is located on the X chromosome. Males have only one X chromosome, so a single pathogenic variant eliminates all functional UPF3B protein. Females have two X chromosomes, so they typically retain some normal protein production from their unaffected copy.
Is UPF3B tested on the NHS?
Yes, UPF3B is included on NHS genomic testing panels for intellectual disability and developmental disorders. Variants in this gene may be analysed and reported when clinicians request genomic testing for individuals with unexplained neurodevelopmental concerns.